Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2022 09:00 ET | Source: INmune Bio, Inc.

INmune Bio, Inc. to Present at the BIO CEO & Investor Conference

BOCA RATON, Florida., Feb. 08, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
January 15, 2019 15:00 ET | Source: INmune Bio, Inc.

INmune Bio, Inc. Announces Pricing of Initial Public Offering

LA JOLLA, CA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (“INmune” or the “Company”), an immunotherapy company focused on developing therapies that harness the patient’s innate immune...